Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients. - Kumar,S.; Boulton,A.J.; Beck-Nielsen,H.; Berthezene,F.; Muggeo,M.; Persson,B.; Spinas,G.A.; Donoghue,S.; Lettis,S.; Stewart-Long,P. (Diabetologia, 1996)